Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1

Status

Unknown 2Terminated 2Completed 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 2Jaundice, Obstructive 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 120sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89pembrolizumab 86Leucovorin 86toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Pancreaticoduodenectomy × Clear all
NCT04089150 2021-10-22

MASTERPLAN

Australasian Gastro-Intestinal Trials Group

Phase 2 Unknown
120 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01941342 2014-01-14

Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy

Southwest Hospital, China

Phase 2 Unknown
274 enrolled
Gastrointestinal

Pancreatic Neoplasms, Jaundice, Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡